- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Greenbrae, California, United States
- Novo Nordisk Investigational Site Mission Hills, California, United States
- Novo Nordisk Investigational Site San Diego, California, United States
- Novo Nordisk Investigational Site Kissimmee, Florida, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,680 public trials
156 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02420262
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Anaheim, California, United States
- Novo Nordisk Investigational Site Bermuda Dunes, California, United States
- Novo Nordisk Investigational Site Fresno, California, United States
NCT00111800
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Pasadena, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Hollywood, Florida, United States
NCT00067951
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
NCT02478190
- Conditions
- Complications of Diabetes Mellitus, Diabetes Complications, Diabetes Mellitus, +7 more
- Locations
-
- Hennepin County Medical Center Minneapolis, Minnesota, United States
NCT00499707
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
NCT00241605
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Calgary, Alberta, Canada
NCT03467659
- Conditions
- Appetitive Behavior, Behavior, Behavior, Animal, +13 more
- Locations
-
- Purdue University West Lafayette, Indiana, United States
NCT03468283
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT02230618
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Guntur, Andhra Pradesh, India
- Novo Nordisk Investigational Site Vijayawada, Andhra Pradesh, India
- Novo Nordisk Investigational Site Visakhapatnam, Andhra Pradesh, India
- Novo Nordisk Investigational Site Ahmedabad, Gujarat, India